Cargando…
Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure
Cell transplantation to repair or regenerate injured myocardium is a new frontier in the treatment of cardiovascular disease. Even though it is based on many years of pre-clinical studies, much remains to be understood about this methodology, even as it progresses to the clinic. For example, controv...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59528/ https://www.ncbi.nlm.nih.gov/pubmed/11806797 http://dx.doi.org/10.1186/cvm-2-5-208 |